Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast.

Abstract

The relationship between estrogen receptor levels and recurrence of breast cancer was examined in 302 patients with adenocarcinoma of the breast, pathologic stage (PS) I and II. All 117 patients with PS II adenocarcinoma of the breast received adjunctive chemotherapy. In this series, there was no association between the estrogen receptor level and recurrence in either the 185 patients with PS I adenocarcinoma of the breast or the 117 patients with PS II adenocarcinoma of the breast. The most important prognostic variable was the presence or absence of axillary metastases.

Statistics

0100200300'86'89'92'95'98'01'04'07'10'13'16
Citations per Year

242 Citations

Semantic Scholar estimates that this publication has 242 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Shapiro1982PrognosticVO, title={Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast.}, author={Calli Shapiro and D J Schifeling and J D Bitran and R K Desser and Hyman Rochman and Andr{\'e} G. Michel and Rita A Shapiro and R R Evans and Mark F. Kozloff and Wendy M Recant and Anthony A. Billings}, journal={Journal of surgical oncology}, year={1982}, volume={19 2}, pages={119-21} }